𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

✍ Scribed by Dinesh Khanna; Chi-Hong Tseng; Niloofar Farmani; Virginia Steen; Daniel E. Furst; Philip J. Clements; Michael D. Roth; Jonathan Goldin; Robert Elashoff; James R. Seibold; Rajeev Saggar; Donald P. Tashkin


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
156 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of oral cyclophosphamide on healt
✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC

The clinical course of lung carcinoma in
✍ Kalpaj Parekh; Valerie Rusch; Mark Kris πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e